Ver el código de «Sodium polystyrene sulfonate»

==General==
*Type: 
*Dosage Forms:
*Common Trade Names: Kayexalate

==Adult Dosing==
===[[Hyperkalemia]]===
*30 gm oral or per rectum

==Pediatric Dosing==
*>1mo: 1 g/kg PO or PR q6hr PRN

==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: B
*Lactation: Not absorbed systemically so infant risk minimal
*Renal Dosing
**Adult
**Pediatric
*Hepatic Dosing
**Adult
**Pediatric

==Contraindications==
*Allergy to class/drug
*Hypokalemia
*Obstructive bowel disease, reduced gut motility
*Rectal administration in neonates, particularly if premature

==Adverse Reactions==
===Serious===
*Intestinal necrosis, ulceration, perforation, fecal impaction
*Bezoars

===Common===
*Abdominal pain, nausea/vomiting, constipation, GI disturbance
*Hypokalemia
*Hypocalcemia
*Hypomagnesemia
*Sodium retention

==Pharmacology==
*Half-life: 
*Metabolism: 
*Excretion: 
*Mechanism of Action: Cation exchange resin, sodium ions partially released from polystyrene and replaced by potassium

==See Also==
*Alternative [[Sodium zirconium cyclosilicate]] (Lokelma)

==References==
<references/>

[[Category:Pharmacology]]
[[Category:FEN]]